Effect of cardiac dysfunction of treatment outcomes in women receiving trastuzumab for HER2-overexpressing metastatic breast cancer.
Clinical Breast Cancer.
Times cited: 28
Cardiac dysfunction in the trastuzumab clinical trials experience.
Journal of Clinical Oncology.
Times cited: 1075
Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses HER2.
New England Journal of Medicine.
Times cited: 8257